Publication | Open Access
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study
30
Citations
26
References
2023
Year
gov as #NCT03217812.
| Year | Citations | |
|---|---|---|
Page 1
Page 1